Applied BioCode Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 107.75 million compared to TWD 67.8 million a year ago. Net loss was TWD 31.58 million compared to TWD 54.72 million a year ago. Basic loss per share from continuing operations was TWD 0.39 compared to TWD 0.67 a year ago. Diluted loss per share from continuing operations was TWD 0.39 compared to TWD 0.67 a year ago.
For the six months, sales was TWD 161.8 million compared to TWD 151.66 million a year ago. Net loss was TWD 105.41 million compared to TWD 78.63 million a year ago. Basic loss per share from continuing operations was TWD 1.29 compared to TWD 0.96 a year ago. Diluted loss per share from continuing operations was TWD 1.29 compared to TWD 0.96 a year ago.